Joslin Leadership

Critical to the success of a world-class institution like Joslin is solid leadership. To maintain the Center's level of excellence in diabetes research, care and education, Joslin's Boards of Trustees and Overseers work in tandem with the executive team. Together, executives and volunteers ensure Joslin is grounded on a steady foundation, yet has the freedom to create new knowledge—a hallmark of this one-of-a-kind Center.

Publicly representing the institution, Joslin's Board comprises local, national and international philanthropic leaders who have a special connection to Joslin and a shared goal of conquering diabetes in all of its forms.

Board of Trustees

W. Ray Allen, Wellesley, MA

John L. Brooks, III, Chairman of the Board, Joslin Diabetes Center, Healthcare Capital Consulting, Medfield, MA

John J. Cook, Jr., Managing Director, Seaward Management Corp., Boston, MA

Nathaniel S. Gardiner, Edwards Angell Palmer & Dodge, Boston, MA

Morella M. Grossmann, Caracas, Venezuela

Ralph M. James, Executive Director, Executive Education, Harvard Business School, Boston, MA

Steven N. Kane, Brookline, MA

Ann M. Lagasse, Newburyport Development, Newburyport, MA

Gary W. Loveman, Chairman, President and CEO, Harrah's Entertainment Inc., Las Vegas, NV

W. Alan McCollough, Atlanta, GA

James L. Peterson, Chardonne, Switzerland

Geoffrey S. Rehnert, Founder and Co-CEO, Audax Management Co. LLC, Boston, Mass.

Richard A. Smith, Chestnut Hill, MA

Ex Officio

Martin J. Abrahamson, M.D., Senior Vice President and Joslin Clinic Medical Director, Joslin Diabetes Center, Boston, MA

George L. King, M.D., Senior Vice President and Research Director, Joslin Diabetes Center, Boston, MA

Kenneth E. Quickel, Jr., M.D., President and CEO, Joslin Diabetes Center, Boston, MA

Honorary Trustees

George F. Cahill, Jr., M.D., Stoddard, NH

Charles H. Hood, Brookline, MA

Patrick H. O’Neill, New Canaan, CT